These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8087389)

  • 1. [Study of primary resistance to antitubercular drugs in Galicia].
    Alvarez D; Valle JM; Martino MV; Gordo P; Carreira J; Valdés L
    Arch Bronconeumol; 1994; 30(6):297-300. PubMed ID: 8087389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antimicrobial resistance in tuberculosis].
    Gutiérrez-Aroca JB; Ruiz P; Casal M
    Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
    Trivedi SS; Desai SG
    Tubercle; 1988 Mar; 69(1):37-42. PubMed ID: 3140458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Mycobacterium tuberculosis in the province of Castellón].
    Moreno R; González F; Pardo F; Andrés Soler J; Prada Alfaro PL
    Arch Bronconeumol; 1996 Mar; 32(3):118-21. PubMed ID: 8634788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-resistant tuberculosis in Sierra Leone.
    Gibson J
    Tubercle; 1986 Jun; 67(2):119-24. PubMed ID: 3095965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
    Uttley AH; Collins CH
    Tubercle; 1988 Sep; 69(3):193-5. PubMed ID: 3151140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
    Esteban J; Ortiz A; Jiménez MS
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):856-7. PubMed ID: 16315010
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group.
    Angarano G; Carbonara D; Costa D
    New Microbiol; 1995 Jan; 18(1):69-72. PubMed ID: 7760759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of tuberculosis. The Mitchell lecture 1979.
    Mitchison DA
    J R Coll Physicians Lond; 1980 Apr; 14(2):91-5, 98-9. PubMed ID: 6767845
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
    Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of drug-resistant Mycobacterium tuberculosis in the province of Castellón. 1992-1998].
    Marín Royo M; González Morán F; Moreno Muñoz R; Pardo Serrano F; Prada Alfaro P; Arnedo Pena A; Aguar Benito MC
    Arch Bronconeumol; 2000 Nov; 36(10):551-6. PubMed ID: 11149197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.
    Fasih N; Rafiq Y; Jabeen K; Hasan R
    PLoS One; 2012; 7(11):e50551. PubMed ID: 23226311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.